Harvard Bioscience Inc. Common Stock (HBIO)
Stock · NASDAQ · Industrials
$8.15as of 10/16/2026
Price chart
Active signals
HBIO Signal Track Record
How signals performed across all stocks →What HBIO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | -3.9% | 36% | September 28, 2026 |
| Bollinger Band Breakdown | 27 | +2.9% | 52% | May 12, 2026 |
| Bollinger Band Breakout | 18 | -6.1% | 28% | October 1, 2026 |
| 200-Day Moving Average TouchActive now | 13 | +5.8% | 62% | July 28, 2026 |
| Any 20-session window (baseline) | -3.2% | 39% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HBIO
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 316
- Website
- www.harvardbioscience.com/
Fundamentals
- 1-day range
- $7.95$8.4
- Market cap
- $27.92M
- P/E (trailing)
- —
- P/E (forward)
- 12.88
- EPS (trailing)
- $-2.32
- Dividend yield
- —
- Beta
- 1.49
- Avg. volume
- 18.0K
How Harvard Bioscience Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 13, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Harvard Bioscience Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HBIOHarvard Bioscience Inc. Common Stock$8.09▼ 2.65%Market cap $27.92MP/E —$3.75$9.4
- ASTCAstrotech Corporation (DE) Common Stock$4.93▼ 5.19%Market cap $18.10MP/E —$1.92$68.85
- PRPOPrecipio Inc. Common Stock$21.38▼ 5.17%Market cap $41.93MP/E —$16.4$33.63
- BNGOBionano Genomics Inc. Common Stock$1.25▼ 8.76%Market cap $12.62MP/E —$1$2.23
- CIRCCircle8 Group Inc. Common Stock$0.302▼ 5.33%Market cap $70.73MP/E —$0.3132$0.98
- RPIDRapid Micro Biosystems Inc. Class A Common Stock$0.764▼ 9.59%Market cap $96.03MP/E —$0.8087$4.94
- NAUTNautilus Biotechnology Inc. Common Stock$2.06▼ 4.63%Market cap $112.76MP/E —$0.8399$4.31
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HBIO Harvard Bioscience Inc. Common Stock | $27.92M | — | $8.09 | ▼ 2.65% | $3.75$9.4 |
| ASTC Astrotech Corporation (DE) Common Stock | $18.10M | — | $4.93 | ▼ 5.19% | $1.92$68.85 |
| PRPO Precipio Inc. Common Stock | $41.93M | — | $21.38 | ▼ 5.17% | $16.4$33.63 |
| BNGO Bionano Genomics Inc. Common Stock | $12.62M | — | $1.25 | ▼ 8.76% | $1$2.23 |
| CIRC Circle8 Group Inc. Common Stock | $70.73M | — | $0.302 | ▼ 5.33% | $0.3132$0.98 |
| RPID Rapid Micro Biosystems Inc. Class A Common Stock | $96.03M | — | $0.764 | ▼ 9.59% | $0.8087$4.94 |
| NAUT Nautilus Biotechnology Inc. Common Stock | $112.76M | — | $2.06 | ▼ 4.63% | $0.8399$4.31 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Harvard Bioscience Announces Creation of Scientific Advisory BoardYahoo · 10/6/2026
Insider Activity
Insider Actions →- Katherine A. Eade · June 9, 2026 · Grant16.6K
- William Snider · June 9, 2026 · Grant16.6K
- Seth Benjamin Benson · June 9, 2026 · Grant16.6K
- Stephen J. Denelsky · June 9, 2026 · Grant16.6K
- Robert E. Gagnon · June 9, 2026 · Grant16.6K
Institutional Ownership
March 31, 2026
- Total shares held
- 1.32M
- Total value held
- $5.54M
- Institutional holders
- 30
- Unknown320.0K
- Unknown179.6K
- Unknown163.3K
- Unknown124.8K
- Unknown114.1K
- Unknown101.4K
- Unknown62.2K
- Unknown59.5K
- Unknown46.3K
- Unknown27.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Harvard Bioscience Forms Scientific Advisory Board
Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.
Harvard Bioscience Forms Scientific Advisory Board. Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.